215 related articles for article (PubMed ID: 10617870)
1. Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients.
Guo Y; Sigman DB; Borkowski A; Kyprianou N
Prostate; 2000 Feb; 42(2):130-6. PubMed ID: 10617870
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in clinically localized prostate cancers of black and white men.
deVere White RW; Deitch AD; Jackson AG; Gandour-Edwards R; Marshalleck J; Soares SE; Toscano SN; Lunetta JM; Stewart SL
J Urol; 1998 Jun; 159(6):1979-82; discussion 1982-3. PubMed ID: 9598502
[TBL] [Abstract][Full Text] [Related]
3. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat.
Xie W; Wong YC; Tsao SW
Prostate; 2000 Jun; 44(1):31-9. PubMed ID: 10861755
[TBL] [Abstract][Full Text] [Related]
4. Elevated caveolin-1 levels in African-American versus white-American prostate cancer.
Yang G; Addai J; Ittmann M; Wheeler TM; Thompson TC
Clin Cancer Res; 2000 Sep; 6(9):3430-3. PubMed ID: 10999725
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer.
Kang JS; Maygarden SJ; Mohler JL; Pruthi RS
BJU Int; 2004 Jun; 93(9):1207-10. PubMed ID: 15180606
[TBL] [Abstract][Full Text] [Related]
6. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression.
Tu H; Jacobs SC; Borkowski A; Kyprianou N
Int J Cancer; 1996 Oct; 69(5):357-63. PubMed ID: 8900367
[TBL] [Abstract][Full Text] [Related]
7. Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as a prognostic marker.
Chia SJ; Tang WY; Elnatan J; Yap WM; Goh HS; Smith DR
Br J Cancer; 2000 Sep; 83(6):761-8. PubMed ID: 10952781
[TBL] [Abstract][Full Text] [Related]
8. African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance.
Kryvenko ON; Balise R; Soodana Prakash N; Epstein JI
J Urol; 2016 Feb; 195(2):301-6. PubMed ID: 26341575
[TBL] [Abstract][Full Text] [Related]
9. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
[TBL] [Abstract][Full Text] [Related]
10. Clearance rates of total prostate specific antigen (PSA) after radical prostatectomy in African-Americans and Caucasians.
Lotan Y; Roehrborn CG
Prostate Cancer Prostatic Dis; 2002; 5(2):111-4. PubMed ID: 12496998
[TBL] [Abstract][Full Text] [Related]
11. Racial differences and prognostic significance of tumor location in radical prostatectomy specimens.
Tiguert R; Gheiler EL; Tefilli MV; Banerjee M; Grignon DJ; Sakr W; Wood DP; Powell IJ; Pontes JE
Prostate; 1998 Dec; 37(4):230-5. PubMed ID: 9831219
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation.
Johnson MI; Robinson MC; Marsh C; Robson CN; Neal DE; Hamdy FC
Prostate; 1998 Dec; 37(4):223-9. PubMed ID: 9831218
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
Cullen J; Lynch JA; Klein EA; Van Den Eeden SK; Carroll PR; Mohler JL; Knezevic D; Farrington TA; Lu R
J Urol; 2021 Apr; 205(4):1047-1054. PubMed ID: 33493001
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.
Amirghofran Z; Monabati A; Gholijani N
Pathol Oncol Res; 2004; 10(1):37-41. PubMed ID: 15029260
[TBL] [Abstract][Full Text] [Related]
16. bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer.
Mackey TJ; Borkowski A; Amin P; Jacobs SC; Kyprianou N
Urology; 1998 Dec; 52(6):1085-90. PubMed ID: 9836559
[TBL] [Abstract][Full Text] [Related]
17. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in prostate cancer: bax correlation with stage.
Amirghofran Z; Monabati A; Gholijani N
Int J Urol; 2005 Apr; 12(4):340-5. PubMed ID: 15948719
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
20. The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach.
Swords K; Wallen EM; Pruthi RS
Urol Oncol; 2010; 28(3):280-4. PubMed ID: 19070516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
